13
13
13
Once CRISPR cuts the DNA at a selected site, the cell’s natural repair mechanisms
step in. There are generally two pathways: non-homologous end joining (NHEJ) and
homology-directed repair (HDR). NHEJ tends to introduce random mutations, which can
knock out or disrupt a gene’s function. HDR, on the other hand, allows scientists
to insert a desired sequence into the DNA, effectively “fixing” or replacing a
faulty segment. These dual pathways enable a wide variety of gene-editing
strategies, from inactivating harmful genes to correcting mutations responsible for
hereditary diseases.
Despite its promising future, CRISPR also raises ethical and safety concerns. Off-
target effects, where unintended parts of the genome get edited, can have
unforeseen consequences. Moreover, editing human embryos or germ cells stirs moral
and regulatory debates about designer babies and potential genetic inequalities.
Scientists and policymakers are working together to develop guidelines ensuring
that CRISPR-based interventions are used responsibly and equitably. The
conversations around this powerful technology underscore the importance of
balancing rapid innovation with caution, transparency, and ethical frameworks.